REBLOZYL
Drug timelines are a Plus or Pro feature.
21 regulatory and trial events tracked for REBLOZYL, covering 2019-11-08 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis [Phase 2]